Recombinant Human Anti-MAPT Antibody (clone Tilavonemab) Preis auf Anfrage

Artikelnummer: CRB-VS-0923-FY255-1
Artikelname: Recombinant Human Anti-MAPT Antibody (clone Tilavonemab) Preis auf Anfrage
Artikelnummer: CRB-VS-0923-FY255-1
Hersteller Artikelnummer: VS-0923-FY255
Alternativnummer: CRB-VS-0923-FY255-1
Hersteller: Creative Biolabs
Kategorie: Antikörper
Tilavonemab is a humanized IgG4 antibody that was developed by C2N Diagnostics and AbbVie to treat tauopathies. It specifically targets an aggregated, extracellular form of pathological tau by binding to amino acids 25-30 in taus N-terminus. By blocking the uptake of tau aggregates in human and mouse neurons, Tilavonemab effectively reduces brain atrophy. This particular form of tau is believed to play a role in the transneuronal propagation of tau pathology in cell-based and mouse models, potentially explaining the characteristic progression of tau pathology in Alzheimers disease.